Opendata, web and dolomites

DE DUVE INSTITUTE (Belgium): list of projects

The following table shows the list of Horizon 2020 projects developed by "DE DUVE INSTITUTE". Projects are ordered by starting date.

Click on table headers to rearrange data.

# acronym  programme  role  EC contrib.  start  views 
1 MESI-STRAT   H2020-EU.3.1.1. participant 289˙000.00 2018-01-01 714
2 Pan3DP   H2020-EU.1.2.1. participant 421˙250.00 2018-10-01 403
3 V.A. Cure   H2020-EU.1.3.1. coordinator 512˙640.00 2019-03-01 402
4 IMMUcan   H2020-EU.3.1.7. participant 0.00 2019-03-01 353
5 TheraLymph   H2020-EU.3.1.3. participant 608˙335.00 2020-01-01 462
totale 1˙831˙225.00

Network analysis

This organization collaborated with partners in 15 countries.

 MESI-STRAT

Within the project MESI-STRAT this organization got in touch with:

role cy shortname name
participant NL SysBioSim B.V. SYSBIOSIM BV (PRC)
participant DE PATH Biobank STIFTUNG PATIENTS TUMORBANK OF HOPE- DIE PATIENTENEIGENE TUMORGEWEBEBANK DER HOFFNUNG (PATH) (REC)
participant DE Neuroimmun GmbH NEUROIMMUN GMBH (PRC)
participant ES VHIO FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (REC)
participant DE HITS HITS GGMBH (REC)
participant DE UKL-HD UNIVERSITATSKLINIKUM HEIDELBERG (HES)
participant UK UDUR UNIVERSITY OF DURHAM (HES)
coordinator AT LFU UNIVERSITAET INNSBRUCK (HES)
participant NO UiT UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET (HES)
participant NL UMCG ACADEMISCH ZIEKENHUIS GRONINGEN (HES)
participant NO UiB UNIVERSITETET I BERGEN (HES)
participant UK UNEW UNIVERSITY OF NEWCASTLE UPON TYNE (HES)
participant DE DKFZ DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG (REC)
participant DE Charite CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES)

 Pan3DP

Within the project Pan3DP this organization got in touch with:

role cy shortname name
participant FR POIETIS POIETIS (PRC)
participant IL TAU TEL AVIV UNIVERSITY (HES)
participant IL TECHNION TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY (HES)
participant CH ETH Zürich EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH (HES)
coordinator UK KCL KING'S COLLEGE LONDON (HES)

 V.A. Cure

Within the project V.A. Cure this organization got in touch with:

role cy shortname name
partner FI TAU TAMPEREEN KORKEAKOULUSAATIO SR (HES)
participant FI FA SINGH PRATEEK (PRC)
partner BE VASCAPA BELGIAN VASCULAR ANOMALY PATIENT ASSOCIATION (OTH)
partner DE Bayer AG BAYER AKTIENGESELLSCHAFT (PRC)
partner DE LLS Rowiak LLS ROWIAK LASERLABSOLUTIONS GMBH (PRC)
partner DE Sysmex Inostics GmbH Sysmex Inostics GmbH (PRC)
partner SE Perimed AB Perimed AB (PRC)
partner BE CUSL CLINIQUES UNIVERSITAIRES SAINT-LUC (REC)
partner SE OLINK BIOSCIENCE AB MOLECULINK AB (PRC)
participant FI UOULU OULUN YLIOPISTO (HES)
participant DE UP UNIVERSITAET POTSDAM (HES)
participant FI UTA TAMPEREEN YLIOPISTO (HES)
participant SE MEDIMMUNE ASTRAZENECA AB (PRC)
participant SE KI KAROLINSKA INSTITUTET (HES)
participant SE UU UPPSALA UNIVERSITET (HES)
participant DE MPG MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV (REC)
participant FR INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC)

 IMMUcan

Within the project IMMUcan this organization got in touch with:

role cy shortname name
participant FR LCC LIGUE NATIONALE CONTRE LE CANCER (REC)
participant FR OWKIN OWKIN FRANCE (PRC)
participant DE Bayer AG BAYER AKTIENGESELLSCHAFT (PRC)
participant US AbbVie ABBVIE INC (PRC)
participant BE IJB INSTITUT JULES BORDET (HES)
participant UK Eli Lilly Eli Lilly and Company Limited (PRC)
participant FR IRIS INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC)
participant FR PIERRE FABRE INSTITUT DE RECHERCHE PIERRE FABRESAS (PRC)
participant FR CLB CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD (REC)
participant FR SARD SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC)
participant LU LIH LUXEMBOURG INSTITUTE OF HEALTH (REC)
participant BE JANSSEN JANSSEN PHARMACEUTICA NV (PRC)
participant LU EPF FORUM EUROPEEN DES PATIENTS (FPE) (OTH)
coordinator BE EORTC EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL (REC)
participant ES CRG FUNDACIO CENTRE DE REGULACIO GENOMICA (REC)
participant CH CHUV CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (PUB)
participant CH SIB SIB INSTITUT SUISSE DE BIOINFORMATIQUE (REC)
participant FR IC INSTITUT CURIE (REC)
participant UK UoB THE UNIVERSITY OF BIRMINGHAM (HES)
participant UK GSK GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC)
participant DE Merck MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC)
participant CH UZH UNIVERSITAT ZURICH (HES)
participant IL WEIZMANN WEIZMANN INSTITUTE OF SCIENCE (HES)
participant UK KCL KING'S COLLEGE LONDON (HES)
participant BE KUL KATHOLIEKE UNIVERSITEIT LEUVEN (HES)
participant DE CHA CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES)
participant FR INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC)

 TheraLymph

Within the project TheraLymph this organization got in touch with:

role cy shortname name
participant FR FTX FLASH THERAPEUTICS (PRC)
participant CH UNIL UNIVERSITE DE LAUSANNE (HES)
participant FR CHUT CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE (HES)
participant CZ CUNI UNIVERZITA KARLOVA (HES)
participant FR IT INSERM - TRANSFERT SA (PRC)
participant BE ULG UNIVERSITE DE LIEGE (HES)
participant SE UU UPPSALA UNIVERSITET (HES)
participant FI UH HELSINGIN YLIOPISTO (HES)
coordinator FR INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC)
participant FR CNRS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (REC)